RGDfC-functionalized gold nanoclusters versus the clinical radiosensitizer sodium glycididazole in triple-negative breast cancer radiotherapy

Radiotherapy for triple-negative breast cancer (TNBC) is often limited by intrinsic tumor radioresistance. The clinically approved radiosensitizer sodium glycididazole (CMNa) is restricted by its hypoxia-dependent activity and lack of tumor targeting. Integrin-targeted gold nanoclusters have been extensively investigated as radiosensitizers, yet direct head-to-head comparisons with CMNa are lacking. We synthesized RGDfC-gold nanoclusters (RGDfC-AuNCs) via one-step biomineralization and compared them with CMNa in 4T1 murine TNBC cells and tumor-bearing mice. The nanoclusters showed ultrasmall size, good stability, and exhibited enhanced cellular uptake relative to non-targeted controls. In vitro, radiosensitization performance was assessed by CCK‑8 assays under normoxic and CoCl2‑mimicked pseudo‑hypoxic conditions. Under equal-total-mass dosing conditions, RGDfC-AuNCs showed superior radiosensitizing trends relative to CMNa across the range of radiation doses tested (2-8 Gy) in both oxygen environments. In 4T1 tumor-bearing mice, RGDfC-AuNCs plus radiotherapy achieved superior tumor growth inhibition (68.29% vs. 50.61%) and a markedly higher sensitization enhancement ratio (2.01 vs. 1.47) compared with CMNa plus radiotherapy, and tumor sections displayed elevated γ-H2AX foci, suggesting enhanced DNA damage. Neither agent induced obvious acute systemic toxicity in hematological, biochemical and histopathological examinations. Collectively, these head‑to‑head observations illustrate the favorable radiosensitization profile of RGDfC‑AuNCs relative to the clinical agent CMNa under the tested conditions, providing a reference for nanocluster-based TNBC radiosensitization.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-16
DOI
https://doi.org/10.1371/journal.pone.0362892
Primary Topic
Radiation Therapy and Dosimetry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

RGDfC-functionalized gold nanoclusters versus the clinical radiosensitizer sodium glycididazole in triple-negative breast cancer radiotherapy

Lingwei Wang, Chunyin Li, Chengbin Qu, Jianyu Xiao et al.
1 links
PLoS ONE
Radiation Therapy and Dosimetry
article

RGDfC-functionalized gold nanoclusters versus the clinical radiosensitizer sodium glycididazole in triple-negative breast cancer radiotherapy

Lingwei Wang, Chunyin Li, Chengbin Qu, Jianyu Xiao, Xiangchao Song
article en

Abstract

Radiotherapy for triple-negative breast cancer (TNBC) is often limited by intrinsic tumor radioresistance. The clinically approved radiosensitizer sodium glycididazole (CMNa) is restricted by its hypoxia-dependent activity and lack of tumor targeting. Integrin-targeted gold nanoclusters have been extensively investigated as radiosensitizers, yet direct head-to-head comparisons with CMNa are lacking. We synthesized RGDfC-gold nanoclusters (RGDfC-AuNCs) via one-step biomineralization and compared them with CMNa in 4T1 murine TNBC cells and tumor-bearing mice. The nanoclusters showed ultrasmall size, good stability, and exhibited enhanced cellular uptake relative to non-targeted controls. In vitro, radiosensitization performance was assessed by CCK‑8 assays under normoxic and CoCl2‑mimicked pseudo‑hypoxic conditions. Under equal-total-mass dosing conditions, RGDfC-AuNCs showed superior radiosensitizing trends relative to CMNa across the range of radiation doses tested (2-8 Gy) in both oxygen environments. In 4T1 tumor-bearing mice, RGDfC-AuNCs plus radiotherapy achieved superior tumor growth inhibition (68.29% vs. 50.61%) and a markedly higher sensitization enhancement ratio (2.01 vs. 1.47) compared with CMNa plus radiotherapy, and tumor sections displayed elevated γ-H2AX foci, suggesting enhanced DNA damage. Neither agent induced obvious acute systemic toxicity in hematological, biochemical and histopathological examinations. Collectively, these head‑to‑head observations illustrate the favorable radiosensitization profile of RGDfC‑AuNCs relative to the clinical agent CMNa under the tested conditions, providing a reference for nanocluster-based TNBC radiosensitization.

PLoS ONEVol. 21(11)
Tianjin Medical University Cancer Institute and Hospital (CN), Tianjin Medical University (CN)
Good health and well-being
Radiation Therapy and Dosimetry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon